Skip to main content
Equibles

Derek Archulo

Analyst

Wells Fargo

Equibles does not estimate personal net worth.

About Derek Archulo

Derek Archulo is recorded as Analyst at Wells Fargo. Derek Archulo has spoken on 2 investor events across 2 companies, most recently for BridgeBio Pharma, Inc. on September 9, 2026. Those appearances were for BridgeBio Pharma, Inc. (BBIO) and Q32 Bio Inc. (QTTB). The companies whose calls Derek Archulo spoke on are classified in the Healthcare sector.

Derek Archulo on recent calls

“Get right back into the fireside discussions. So my name is Derek Archula. I'm one of the biotech analysts here at Wells Fargo. Really excited to have next here Bridge Bio from the company.”
Analyst — Wells Fargo, 21st Annual Wells Fargo Healthcare Conference ·
“I'm one of the senior biotech analysts here at Wells Fargo, and I'm very happy to have Q32Bio for our next fireside. So from the company, we have Jody Morrison, CEO, Sheila Violette, CSO, and Lee Kowalski, CFO.”
Analyst — Wells Fargo, Wells Fargo 21st Annual Healthcare Conference ·

Affiliation history

  • Wells Fargo

    Analyst

    Source not stated

    Current

Company network

Recent activity